We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $871M
1-Year Est. Return 64.45%
This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+64.45%
3 Year Est. Return
+183.15%
5 Year Est. Return
+262.44%
10 Year Est. Return
AUM
$606M
AUM Growth
-$7.07M
Cap. Flow
-$14.8M
Cap. Flow %
-2.44%
Top 10 Hldgs %
57.56%
Holding
76
New
1
Increased
4
Reduced
38
Closed
8

Top Buys

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$5.93M
2
PYPL icon
PayPal
PYPL
+$3.9M
3
MMM icon
3M
MMM
+$2.03M
4
DE icon
Deere & Co
DE
+$312K
5
GLW icon
Corning
GLW
+$110K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$4.26M
2
DIS icon
Walt Disney
DIS
+$4.07M
3
CNC icon
Centene
CNC
+$2.49M
4
INTC icon
Intel
INTC
+$2.28M
5
ADBE icon
Adobe
ADBE
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 33.96%
2 Healthcare 23.33%
3 Financials 14.81%
4 Industrials 8.86%
5 Communication Services 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
26
Danaher
DHR
$144B
$6.62M 1.09%
28,855
-5,325
-16% -$1.31M
AXON
27
Axon Enterprise
AXON
$46.4B
$6.48M 1.07%
+10,911
New +$5.93M
AWK icon
28
American Water Works
AWK
$26.9B
$5.63M 0.93%
45,234
CLH icon
29
Clean Harbors
CLH
$16.3B
$5.59M 0.92%
24,300
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5.37M 0.89%
64,246
-585
-0.9% -$48.1K
PYPL icon
31
PayPal
PYPL
$50.5B
$5.24M 0.87%
61,417
+46,417
+309% +$3.9M
IBM icon
32
IBM
IBM
$224B
$4.99M 0.82%
22,715
-240
-1% -$53.5K
GE icon
33
GE Aerospace
GE
$384B
$4.9M 0.81%
29,383
-88
-0.3% -$15.7K
CARR icon
34
Carrier Global
CARR
$52.8B
$4.68M 0.77%
68,555
MDT icon
35
Medtronic
MDT
$112B
$4.56M 0.75%
57,056
-250
-0.4% -$21.6K
CAT icon
36
Caterpillar
CAT
$387B
$4.48M 0.74%
12,347
XOM icon
37
ExxonMobil
XOM
$634B
$4.41M 0.73%
41,038
KO icon
38
Coca-Cola
KO
$375B
$4.1M 0.68%
65,793
-796
-1% -$52K
MRK icon
39
Merck
MRK
$318B
$3.84M 0.63%
38,600
-550
-1% -$56.7K
HES
40
DELISTED
Hess
HES
$2.74M 0.45%
20,637
-200
-1% -$27.9K
PFE icon
41
Pfizer
PFE
$153B
$2.68M 0.44%
101,028
-44,840
-31% -$1.22M
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$126B
$2.57M 0.42%
6,392
OTIS icon
43
Otis Worldwide
OTIS
$28.2B
$2.5M 0.41%
26,944
GEV icon
44
GE Vernova
GEV
$264B
$2.41M 0.4%
7,322
-16
-0.2% -$5K
SPY icon
45
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$2.11M 0.35%
3,593
AMD icon
46
Advanced Micro Devices
AMD
$789B
$2.07M 0.34%
17,146
-5,740
-25% -$826K
CMCSA icon
47
Comcast
CMCSA
$90B
$1.94M 0.32%
51,788
-2,568
-5% -$107K
MRNA icon
48
Moderna
MRNA
$23.6B
$1.91M 0.32%
45,942
-80
-0.2% -$3.82K
TXN icon
49
Texas Instruments
TXN
$261B
$1.91M 0.31%
10,160
AVGO icon
50
Broadcom
AVGO
$2.04T
$1.51M 0.25%
6,500

Similar funds

J.P. Marvel Investment Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, J.P. Marvel Investment Advisors held 76 positions worth $606M, down 1.2% from $613M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

J.P. Marvel Investment Advisors's Q4 2024 filing shows 1 new, 4 increased, 38 reduced and 8 closed positions. Its largest new stake was Axon Enterprise: 10,911 shares worth $6.48M. The largest sale was CVS Health, an estimated $4.26M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

  • J.P. Marvel Investment Advisors's largest Q4 2024 buy was Axon Enterprise: 10,911 shares worth $6.48M.
  • J.P. Marvel Investment Advisors added most to PayPal in Q4 2024, an estimated $3.9M increase.
  • J.P. Marvel Investment Advisors's biggest Q4 2024 reduction was Walt Disney, cutting an estimated $4.07M.
  • J.P. Marvel Investment Advisors fully exited CVS Health in Q4 2024, selling an estimated $4.26M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 58% of its $606M portfolio in Q4 2024.
  • J.P. Marvel Investment Advisors opened 1 new position and closed 8 in Q4 2024.
  • J.P. Marvel Investment Advisors's portfolio value fell 1.2% quarter-over-quarter to $606M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q4 2024, filed 30 Jan 2025.